Roswell Park Cancer Institute: Neoplasms trials
The registry lists 28 Neoplasms studies with Roswell Park Cancer Institute as lead sponsor. 0 are open to participants now and 5 have results posted.
Early Phase 1 1Phase 1 10Phase 2 6Phase 3 1No phase 11(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Impact of Early Mobility on Post-Surgery Recovery in Patients Undergoing Oncologic SurgeriesTerminatedNCT04000581Not applicableResults posted
- Nintedanib in Treating Patients With Locally Advanced or Metastatic Neuroendocrine TumorsCompletedNCT02399215Phase 2Results posted
- Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate CancerCompletedNCT00970203Phase 2Results posted
- High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid TumorsCompletedNCT00536601Not applicableResults posted
- Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic CancerCompletedNCT00003816Phase 2/3Results posted
- ivWatch in Prevention of Extravasation of Vesicants in an Oncology SettingCompletedNCT06758011Not applicable
- Financial Health Educational Program for Increasing Financial Literacy Among Underserved Communities in Western New YorkCompletedNCT05997589Not applicable
- Thermal Therapy for the Treatment of Depression in Cancer Survivors, the S-WARM StudyWithdrawnNCT04803630Early Phase 1
- Yoga Intervention for the Improvement of Cancer-Related Stress in Cancer SurvivorsCompletedNCT04754529Not applicable
- Weight Loss Interventions for Black Adults of FaithCompletedNCT04557540Not applicable
- Parenting Skills Intervention in Improving Medication Adherence in Pediatric Cancer PatientsCompletedNCT03895918Not applicable
- Physical Activity Monitored by Fitbit Charge 2 in Improving Quality of Life in Participants With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT03685695Phase 2
- Talking Pictures Social Media Intervention in Reducing Depressive Symptoms and Improving Spiritual Well-Being and Quality of Life in Adolescent and Young Adult Cancer PatientsCompletedNCT03679585Not applicable
- Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With CancerCompletedNCT01896778Not applicable
- Radiation Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Receiving Sipuleucel-TCompletedNCT01833208Not applicable
- Gemcitabine Hydrochloride and Smac Mimetic TL32711 in Treating Patients With Advanced Solid TumorsTerminatedNCT01573780Phase 1
- Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell TransplantWithdrawnNCT01558778Not applicable
- PI3K Inhibitor BKM120 and Docetaxel in Treating Patients With Advanced Solid Tumor That is Locally Advanced, Cannot Be Removed By Surgery, or MetastaticCompletedNCT01540253Phase 1
- Cisplatin in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer or Lung MetastasisCompletedNCT01014598Phase 1
- Irinotecan and Selenium in Treating Patients With Advanced Solid TumorsCompletedNCT00112892Phase 1
- Docetaxel, Capecitabine, and Cisplatin in Treating Patients With Advanced Solid TumorsCompletedNCT00084734Phase 1
- Calcitriol and Gefitinib With or Without Dexamethasone in Treating Patients With Advanced Solid TumorsCompletedNCT00084708Phase 1
- High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid TumorsCompletedNCT00060255Phase 2
- Irinotecan and Gemcitabine in Treating Patients With Refractory Advanced Solid TumorsCompletedNCT00054288Phase 1
- S-3304 in Treating Patients With Advanced Solid TumorsCompletedNCT00033566Phase 1
- Irinotecan Followed by Fluorouracil in Treating Patients With Advanced Solid TumorsCompletedNCT00024141Phase 1
- Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow TransplantCompletedNCT00003894Phase 2
- Anhydrovinblastine in Treating Patients With Advanced Recurrent Solid TumorsCompletedNCT00003882Phase 1